Physician
Health Care Solutions PA
Health Care Solutions PA was paid $1.88M by Medicaid between Jan 2018 and Dec 2024, across 41 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 67% of everything it billed.
33Billing provider infoHEALTH CARE SOLUTIONS PA
RUIDOSO, NM 88345
RUIDOSO, NM 88345
33aNPI1366410771assigned 03/10/2006
33bProvider typeFamily Medicine Physician
28Total paid$1.88M
24GClaims28,651
24DCodes billed41
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in New Mexico
Rank by total paid#22 of 148
Median peer was paid$167K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,251 | $95K | |
| 2019 | 2,606 | $169K | |
| 2020 | 2,561 | $192K | |
| 2021 | 3,118 | $245K | |
| 2022 | 3,254 | $220K | |
| 2023 | 5,202 | $404K | |
| 2024incomplete | 10,659 | $556K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 67% | 12,983 | 11,565 | $1.27M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 3,767 | 3,528 | $299K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 7.3% | 940 | 876 | $137K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.7% | 276 | 271 | $50K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.2% | 175 | 174 | $22K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 1,131 | 551 | $21K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.0% | 535 | 481 | $20K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 500 | 487 | $17K |
| 80305 | <1% | 965 | 844 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 591 | 519 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 438 | 431 | $8K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 178 | 164 | $4K |
29 more codes
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 70 | $4K |
| 99072 | <1% | 33 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 14 | $2K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 14 | $2K |
| 96127 | <1% | 140 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 17 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 47 | $1K |
| 81002 | <1% | 264 | $965.01 | |
| 93000 | <1% | 13 | $213.28 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 12 | $124.75 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 13 | $39.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 15 | $35.39 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 26 | $12.19 |
| 1160F | 0% | 970 | $0.00 | |
| 3078F | 0% | 742 | $0.00 | |
| 1159F | 0% | 971 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 91 | $0.00 |
| 3077F | 0% | 214 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 38 | $0.00 |
| 3075F | 0% | 150 | $0.00 | |
| 3079F | 0% | 271 | $0.00 | |
| 1170F | 0% | 435 | $0.00 | |
| 4010F | 0% | 301 | $0.00 | |
| 3074F | 0% | 869 | $0.00 | |
| 4050F | 0% | 181 | $0.00 | |
| 3080F | 0% | 187 | $0.00 | |
| 3044F | 0% | 15 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 43 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSINGH, ABHINAV (MEDICAL DIRECTOR)